drugset / Trial / NCT02485431

Food Effect and Bioavailability of Deflazacort Formulations in Healthy Volunteers

NCT02485431

RandomizedCrossoverOpen-labelOther

Summary

This is a Phase 1, single-center, single-dose, randomized, 5-period crossover study designed to assess the comparative bioavailability and food effect of deflazacort. A total of 45 subjects will be randomly assigned to receive 1 of 5 treatment sequences. Each dosing sequence will be enrolled in parallel and all subjects will receive all 5 treatments in a crossover fashion.

Timeline

Start
2015-06
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Deflazacort Other / unclassified 36 mg Oral

Indications

No indication recorded.